HCA
ABBV icon

Heck Capital Advisors’s AbbVie ABBV Stock Holding History

Heck Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,880
Closed -$429K – 203
2025
Q4 		$429K Buy
+1,880
New +$428K 0.03% 163
2025
Q1 		– Sell
-5,358
Closed -$952K – 238
2024
Q4 		$952K Buy
+5,358
New +$985K 0.04% 141

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Heck Capital Advisors's ABBV Position: Q1 2026 in Review

Heck Capital Advisors sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 1,880 shares — an estimated $429K sold.

Heck Capital Advisors first reported a position in ABBV in Q4 2024 and held it in 2 quarters. The position peaked at $952K in Q4 2024. 4,112 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Heck Capital Advisors reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Heck Capital Advisors sold 1,880 AbbVie shares in Q1 2026, an estimated $429K.
  • Heck Capital Advisors first reported a position in AbbVie in Q4 2024 and held it in 2 quarters.
  • Heck Capital Advisors's AbbVie position peaked at $952K in Q4 2024.
  • 4,112 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Heck Capital Advisors's 13F filing for Q1 2026, filed 16 Apr 2026.